Перейти к содержимому

Which GLP-1 Is Actually BEST?

Susan Brian MD

0:00 / 0:00

Which GLP-1 Is Actually BEST?

6 477 просмотров · 5 дней назад
Susan Brian MD
3,98 тыс. подписчиков
6 477 просмотров · 5 дней назад
Ozempic vs. Wegovy vs. Mounjaro vs. Zepbound — what’s the difference, and which GLP-1 medication is actually best? If you’re confused about Ozempic, Wegovy, Mounjaro, and Zepbound, you are NOT alone. These medications are among the most talked-about treatments for type 2 diabetes and obesity, but they are not all the same. In this video, I break down the important differences between these GLP-1 medications — including semaglutide vs. tirzepatide, diabetes vs. weight-loss indications, how they work, weight loss results, blood sugar control, dosing, side effects, gastrointestinal symptoms, and what we actually know from the research. We’ll compare: • Ozempic (semaglutide) • Wegovy (semaglutide) • Mounjaro (tirzepatide) • Zepbound (tirzepatide) I’ll explain why Ozempic and Wegovy contain the same active medication, why Mounjaro and Zepbound contain the same active medication, and why the FDA-approved indications and doses are different. We’ll also talk about GLP-1 receptor agonists, GIP/GLP-1 medications, weight loss injections, obesity treatment, type 2 diabetes medications, appetite suppression, metabolic health, and the side effects you should know about before starting one of these medications. And most importantly: Is one medication really “better” than the others? The answer is more nuanced than what you may hear on social media. I’m Dr. Susan Brian, a board-certified endocrinologist and menopause specialist. I’ve been prescribing GLP-1 medications for more than 20 years, and my goal with this channel is to take the medical research and make it understandable — without the hype and without the fear. DISCLAIMER: This video is for educational purposes only and is not medical advice. Medication decisions should be made with your own healthcare professional. I also have worked with various pharmaceutical companies for the past 10+ years in many research trials as a clinical researcher, including many GLP1 trials, but this is not sponsored by any pharmaceutical company and these are my own opinions- also no inside information.  #Ozempic #Wegovy #Mounjaro #Zepbound #GLP1 #GLP1Medications #WeightLoss #WeightLossMedication #Type2Diabetes #Tirzepatide #Semaglutide #ObesityMedicine #Endocrinology